The need for rigorous compliance with regulations and strict adherence to best-practice surrounding the quality, safe, and efficient manufacturing and distribution of medicines has never been greater.
With this joint roundtable session, our goal is to discuss and debate smart quality approaches in the pharmaceutical sector to help promote, standardize, monitor, and assess adherence to the GMP (good manufacturing practice) and GDP (good distribution practice) regulations that underpin the pharmaceutical industry.